title: Inhaled iloprost in lung transplantation: can it avoid extracorporeal circulation in patients with severe pulmonary hypertension?
authors.affiliation: Department of Anaesthesiology, Hannover Medical School, Hannover, Germany. Winterhalter.Michael@mh-hannover.de <Winterhalter.Michael@mh-hannover.de>
authors.forename: Michael
authors.initials: M
authors.lastname: Winterhalter
authors.forename: Andre
authors.initials: A
authors.lastname: Simon
authors.forename: Stefan
authors.initials: S
authors.lastname: Fischer
authors.forename: Clemens
authors.initials: C
authors.lastname: Gras
authors.forename: Janusz
authors.initials: J
authors.lastname: Zuk
authors.forename: Siegfried
authors.initials: S
authors.lastname: Piepenbrock
authors.forename: Martin
authors.initials: M
authors.lastname: Strüber
mesh_terms: D000280:Administration, Inhalation; D000328:Adult; D000075202:Contraindications; D005112:Extracorporeal Circulation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D016285:Iloprost / Q000008:administration & dosage*; D007432:Intraoperative Period; D016040:Lung Transplantation / Q000379:methods*; D011656:Pulmonary Emphysema / Q000150:complications / Q000601:surgery*; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000008:administration & dosage*
chemical_list: D014665:Vasodilator Agents; D016285:Iloprost